Welcome!

Cognitive Computing Authors: Progress Blog, Liz McMillan, Pat Romanski, Kevin Benedict, Mehdi Daoudi

News Feed Item

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024

NEW YORK, Jan. 6, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024

http://www.reportlinker.com/p0572966/Pharmaceutical-Anti-counterfeiting-Technologies-Market-Analysis-2014-2024.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

Report Details

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 - your guide to developments, opportunities and revenues

Where is the pharmaceutical anti-counterfeiting industry heading? Visiongain's brand new report lets you assess forecasted sales at overall world market, submarket, and national level to 2024.

Our 169 page study investigates technologies to tackle drug counterfeiters. Discover the most lucrative areas in that industry and market, seeing future outlooks.

Forecasts from 2014-2024 and other analyses show you commercial prospects

Besides revenue forecasting to 2024, our new study provides you with historical data, recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments (R&D). Discover qualitative analyses (SWOT and STEP), company profiles and commercial developments. You also receive two interviews, and 90 tables, figures and charts

You will find prospects for key technology submarkets

In addition to analyses of the overall world market, you see revenue forecasting of five technology submarkets to 2024:
• RFID (radio frequency identification)
• Security printing
• Taggants
• Holograms/OVD (optical variable devices)
• Other pharma anti-counterfeiting technologies

Our investigation shows business research and analysis with individual revenue forecasts and discussions.

Prospects for leading countries are shown to 2024

Events and progress worldwide will influence the market, especially rising demand for supply chain security measures such as track-and-trace systems. Growth in this market will be fuelled by government mandates requiring serialisation solutions on products.

You discover individual revenue forecasts to 2024 for these geographical markets:
• US
Japan
Germany, France, UK, Italy and Spain (EU5 Countries, as a group)
Brazil
Russia
India
China
• RoW

The expected launch of new technologies from 2013 onwards will benefit regional and national markets. Greater uptake of existing technology worldwide will also stimulate the industry and market.

Companies and overall 2016 market revenue - what predicted growth?

Overall world revenue for pharmaceutical anti-counterfeiting technologies will reach $1.11bn in 2014. Rising concerns about counterfeit drugs worldwide will stimulate demand for drug security, authentication and verification solutions.

Our work profiles leading companies, assessing their technologies and products. You will see which technologies and organisations hold greatest potential.

In particular, we profile these leading organisations:
• 3M
• Authentix
• Alien Technology
• Colorcon
• NanoGuardian
• Thermo Scientific
• Angstrom Technologies
• AlpVision
Avery Dennison
• Chesapeake
• Covectra
• Everest Holovisions
• InkSure Technologies
• Covectra
• Intermec
• TruTag Technologies
• UPM Raflatac
• Zebra Technologies

What issues decide the future of the industry and market?

Our study lets you assess industry trends and outlooks. You will find discussions of many issues and developments, including R&D:
• Parallel trade of medical products
• Activities of trade bodies and governmental organisations
• Security and efficiency of the pharma supply chain
• Wholesalers and other pharma intermediaries
• Actions taken by pharma companies
• Trading channels and drug counterfeiters
• Standards, regulations and policies

You see discussions of social, technological, economic and political matters, with emphasis on competing organisations and those shaping policy. Find out what the future holds.

Our investigation gives you multi-level business research and analysis with sales forecasts. You will see how the industry and market can perform from 2014 to 2024.

How the Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 report helps you

In summary, our report gives you the following knowledge:
• Revenues forecasts to 2024 for the overall world pharmaceutical anti-counterfeiting technologies market and 5 submarkets - discover the industry's prospects
• Revenues forecasts to 2024 for 5 pharmaceutical anti-counterfeiting technologies submarkets - discover promising areas for investments and revenues
• Market forecasting to 2024 for the 8 key regions: US, Japan, leading EU countries (Germany, France, the UK, Italy and Spain), India, China, Brazil and Russia
• Profiles of 17 prominent companies - assess product ranges, developments and strategies
• Competition and opportunities - see what factors affect the pharmaceutical anti-counterfeiting market, learning what shapes its future, esp. prospects for sustaining and developing business
• Opinions from our survey, seeing interviews with leading industry experts AlpVision and also a Leading Anti-counterfeiting Technologies Company Based in the US.

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed on business intelligence.

1. Executive Summary

1.1 Market Highlights
1.2 Overview of the Report Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Related to Pharmaceutical Anti-counterfeiting Technologies

2. Introduction to Pharmaceutical Counterfeiting

2.1 Drug Counterfeiting: A Thorn in the Side of the Pharma Industry
2.1.1 Regional Differences Hindering Information Exchange
2.1.2 Rising Counterfeiting Incidents in Developed Regions
2.2 The Most Commonly Counterfeited Drugs
2.3 Types of Counterfeit Drugs
2.3.1 Substandard Pharmaceutical Products as Counterfeits
2.3.2 Global Outsourcing of Active Pharmaceutical Ingredients (APIs)
2.3.2.1 Heparin Contamination
2.3.2.2 Stricter Enforcement needed for API Control
2.4 Why are Drugs Counterfeited?
2.4.1 Methods of Producing Pharmaceutical Counterfeits
2.4.2 Moving Counterfeits into the Pharmaceutical Supply Chain
2.4.3 Corruption Within the Pharmaceutical Distribution System
2.5 The Internet and its Role in Pharmaceutical Counterfeiting
2.5.1 Online Pharmacies: A Cheap Distribution System for Pharma Counterfeits
2.5.2 Legal Online Pharmacies: A Convenient and Quick Way of Dispensing Medication
2.5.3 Verifying the Authenticity of Online Pharmacies
2.6 Pharmaceutical Counterfeiting: The Global Costs
2.6.1 The Impact of Pharmaceutical Counterfeiting on Consumers
2.6.2 The Impact of Counterfeiting on Healthcare Providers
2.6.3 The Impact of Counterfeiting on Pharma Manufacturers
2.6.4 The Impact of Pharmaceutical Counterfeiting on Governments
2.6.5 The Impact of Counterfeiting on the Global Pharmaceutical Industry
2.6.5.1 Operation Pangea: Europol's Fight Against Counterfeiting
2.6.5.2 Legislative Deficiencies Aiding Counterfeiting Operations
2.7 Factors Fuelling Pharmaceutical Counterfeiting
2.7.1 An Erratic Supply or Shortage of Drugs Promotes Counterfeiting
2.7.2 Price Differentials and High Price Medicines Drive People to Cheaper Counterfeit Alternatives
2.7.3 Drug Misuse Creates a Market for Counterfeiting
2.7.4 Trade through Free-Trade Zones/Free Ports Is an Important Route for Counterfeiters
2.7.5 The Trade of Pharmaceuticals through Several Intermediaries Helps Hide Counterfeit Drugs
2.7.6 Counterfeiters Target Developed Markets
2.7.7 Parallel Trade - a Counterfeiting Route in Europe

3. Leading Technologies and Applications

3.1 Passive Technologies
3.1.1 Security Inks as Anti-counterfeiting Technologies
3.1.2 Holograms as Anti-counterfeiting Technologies
3.1.3 Visual Inspection as the First Line of Defence Against Drug Counterfeiting
3.1.4 Overt and Hidden Imaging
3.2 Active Technologies
3.2.1 Electromagnetic Tags - Radio Frequency Identification (RFID) as Anti-counterfeiting Technologies
3.2.2 Taggants as Anti-counterfeiting Technologies
3.2.3 Mass Encoding Technology
3.2.3.1 Digital Mass Serialisation Technology (DMS)
3.2.3.2 Digital Mass Encryption (DME)
3.2.3.3 Barcode Applications: Serialisation is Key

4. Leading Companies in the Pharmaceutical Anti-counterfeiting Technologies Market

4.1 3M: A Diversified Technology Multinational
4.2 Alien Technology: RFID Technology Specialist
4.3 AlpVision: Cryptoglyph Security Solution
4.3.1 Fingerprint: A 'Read Only' Technology
4.3.2 Krypsos Platform
4.3.3 Cryptoglyph
4.3.4 AlpVision: Integration of Phone Applications Important for Future Growth
4.4 Angstrom Technologies - Security Inks
4.5 Authentix: Product Authentication and Brand Protection
4.5.1 Product-specific Track-and-Trace Solutions
4.5.2 Packaging Solutions
4.6 Avery Dennison: RFID Technologies Expert
4.7 Colorcon
4.7.1 Colorcon's Taggants: On-Dose ID
4.7.2 Colorcon's Brand Enhancement Service
4.8 Chesapeake: Acquired by The Caryle Group
4.9 Covectra
4.9.1 Covectra's Authenti-Track System for Product Tracing
4.9.2 Covectra's ControlTrack System for Combating Opioid Drug Diversion
4.10 Everest Holovisions
4.11 InkSure Technologies: Leader in Cloud-based Authentication
4.12 Intermec: A Workflow Performance Company
4.12.1 Automatic Information Data Capture
4.12.2 Will Recent Acquisitions Spell an Uncertain Future?
4.13 NanoGuardian
4.13.1 NanoCodes: Data Carriers of Limitless Potential
4.13.2 NanoGuardian's Global Licensing Agreement with Capsugel
4.13.3 The Closed-Loop Protection System
4.13.4 Major Players Showing Interest In NanoGuardian's Technologies
4.14 ThermoFisher Scientific
4.14.1 Acquisition of Ahura Scientific
4.14.2 Continous Growth and Expansion into Emerging Markets
4.14.3 ThermoFisher Scientific's TruScan Technology
4.15 TruTag Technologies
4.15.1 TruTag's Silica Microtag Technology
4.16 UPM Raflatac
4.17 Zebra Technologies

5. Global Pharmaceutical Anti-counterfeiting Technologies Market 2014-2024

5.1 Pharmaceutical Anti-counterfeiting Technologies: Market Overview
5.1.1 Size of the Pharmaceutical Anti-counterfeiting Technologies Market in 2012 and
2013
5.1.2 Global Pharmaceutical Anti-counterfeiting Technologies Market: Growth Trends
5.1.3 Global Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2012-2017
5.1.4 Global Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2017-2024
5.1.5 Changing Market Shares by Sector, 2012-2024
5.2 Pharmaceutical RFID Market Forecast 2012-2024
5.3 Pharmaceutical Security Printing Market Forecast 2012-2024
5.4 Pharmaceutical Taggants Market Forecast 2012-2024
5.5 Pharmaceutical Hologram/OVD Market Forecast 2012-2024
5.6 Other Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2012-2024

6. Leading National Markets 2014-2024

6.1 Pharmaceutical Counterfeiting: A Global Conundrum
6.1.1 How Will National Market Shares Change to 2024?
6.2 Regional Pharmaceutical Anti-counterfeiting Market Forecast, 2014-2024
6.2.1 The US Market
6.2.2 EU5: Europe's Leading Anti-counterfeiting Technology Markets
6.2.3 Japan: Uptake of Key Technologies Important for Market Growth
6.2.4 China: Set to See High Growth Rates Continue Until 2017
6.2.5 India: New Mandates will Help Deter Counterfeiters
6.2.5.1 Collaboration with the WHO will Help Regain Consumer Confidence in Pharma Products
6.2.6 Brazil: South America's Largest Pharmaceutical Market
6.2.7 Russia: Highest Per-Capita Spending on Healthcare of All the BRIC Nations

7. Issues Affecting the Pharmaceutical Anti-counterfeiting Technologies Market

7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2014-2024
7.2 Strengths
7.2.1 Growing Interest from Pharmaceutical Companies in Tackling Counterfeiting
7.2.1.1 AstraZeneca
7.2.1.2 GlaxoSmithKline
7.2.1.3 Johnson & Johnson
7.2.1.4 Novartis
7.2.1.5 Pfizer
7.2.1.6 Sanofi
7.2.2 Organisations Promoting the Awareness and Implementation of Anti-Counterfeiting Solutions
7.2.2.1 Anti-counterfeiting and Product Protection Programme (A-CAPPP)
7.2.2.2 Anti-counterfeiting Group (ACG)
7.2.2.3 Brazil's National Health Surveillance Agency (ANVISA)
7.2.2.4 Canadian Anti-counterfeiting Network (CACN)
7.2.2.5 Center for Healthcare Supply Chain Research
7.2.2.6 European Alliance for Access to Safe Medicines (EAASM)
7.2.2.7 European Federation of Pharmaceutical Industries and Associations (EFPIA)
7.2.2.8 International Anti-counterfeiting Coalition (IACC)
7.2.2.9 International Authentication Association (IAA)
7.2.2.10 The Pharmaceutical Security Institute (PSI)
7.2.3 Track-and-Trace Solutions Boosting Supply Chain Efficiency
7.2.4 New Technologies Providing More Comprehesive Anti-Counterfeiting Protection
7.2.5 Litigation Proceedings over Counterfeit Products Affecting Profitability
7.3 Weaknesses
7.3.1 The Lack of Standardisation Across the Industry as a Whole Will Impede Technology Adoption
7.3.2. Insufficient Quantitative Measurement of the Effectiveness of Anti-counterfeiting Technologies
7.3.2.1 Complexity of Factors Influencing Drug Revenue Makes Quantifying Commercial Impact of Anti-counterfeiting Technologies Difficult
7.3.3 Technology Reliability and the Ease of Integration into Manufacturing Processes
7.3.4 Lack of Cooperation Between Various Governmental Organisations Aids Drug
Counterfeiters
7.4 Opportunities
7.4.1 Constantly Evolving Technologies Allows for Product Innovation
7.4.2 Anti-counterfeiting Technologies for the Prevention of Online Fraud
7.5 Threats
7.5.1 The High Volume of Counterfeiting Activities Could Devalue Anti-counterfeiting
Solutions
7.5.2 Developing Countries Lack Infrastructure to Effectively Deal with Counterfeiting
7.5.3 Pace of Innovation May Not Keep up with the Counterfeiters
7.6 STEP Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2014-2024
7.6.1 Social Factors
7.6.1.1 The Weak Enforcement of Legislation
7.6.1.2 Corruption: A Hindrance to Eradicating Pharmaceutical Counterfeiting
7.6.1.3 Changing Public Perception and Consumer Education
7.6.1.4 Concerns Over Information Privacy
7.6.2 Technological Factors
7.6.2.1 Smartphone Read and Verify: A Customer Empowerment Tool
7.6.2.2 US FDA's Counterfeit Detection Device
7.6.2.3 UV and IR Inks Being Used Covertly for Increased Security
7.6.2.4 Bokode: A Potential Replacement for Barcodes?
7.6.2.5 SigNature DNA
7.6.3 Economic Factors
7.6.3.1 Implementation Costs of Anti-counterfeiting Technologies
7.6.3.2 Anti-counterfeiting Technologies Require R&D Investment
7.6.4 Political Factors
7.6.4.1 World Health Organization: The IMPACT Programme
7.6.4.2 Anti-Counterfeiting Trade Agreement (ACTA)
7.6.4.3 The Fagan Civil Case: Effects of Litigation on Players in the Drug Supply Chain
7.6.4.4 Legislations for Supply Chain Security
7.6.4.5 E-pedigree: A Catalyst for Product Serialisation
7.6.4.5.1 E-pedigree: Challenges Involved in Implementation
7.6.4.5.2 EU and the US: Differing Supply Chain Authentication
7.6.4.6 UK MHRA: Falsified Medical Products Strategy
7.6.4.7 The EU's Falsified Medicines Directive

8. Expert Opinions

8.1 Interview with Dr Fred Jordan, Chief Executive Officer, AlpVision
8.1.1 Current State of Counterfeiting in the Pharmaceutical Industry
8.1.2 AlpVison's Key Technologies and Strategies for Combating Counterfeiters
8.1.3 The Future of Anti-counterfeiting Technologies
8.1.4 On Whom do the Responsibilities for Counterfeiting Prevention Lie?
8.1.5 The Major Barriers Facing Implementation of Anti-counterfeiting Technologies
8.1.6 Future Growth Drivers of the Anti-counterfeiting Technologies Market
8.2 Interview with a Spokesperson from a Leading Anti-counterfeiting Technologies Company Based in the US.
8.2.1 On the Threats Posed by Counterfeit Products
8.2.2 Keeping Up with the Counterfeiters: An Impossible Task?
8.2.3 Duty of Care
8.2.4 DNA Technology: The Innovation Needed to Defeat Counterfeiting?
8.2.5 Future Prospects of the Pharma Anti-counterfeiting Industry

9. Conclusion

9.1 The Pharmaceutical Anti-counterfeiting Technologies Industry 2014-2024
9.2 Government Mandates Will Fuel Growth in the Market
9.3 The US Will Continue to Dominate the Market
9.4 New Directives Will Ensure Track-and-Trace Market Leadership
9.5 European Preference for Mandated 2D Barcode Technology
9.6 Improved Regulation of Online Pharmacies Necessary for Anti-counterfeiting Technologies to be Effective
9.7 Market Expansion Will be Dependent on the Development of Industry-Wide Standards for the Use of the Available Technologies

List of Tables

Table 2.1 Global Reported Incidents of Drug Counterfeiting, 2008-2012
Table 2.2 Classification of Counterfeit Pharmaceutical Products
Table 3.1 Anti-counterfeiting Technologies Used in the Pharmaceutical Industry
Table 3.2 Leading Anti-counterfeiting Security Ink Manufacturers, 2013
Table 3.3 Leading Anti-counterfeiting Holographic Labelling Manufacturers, 2013
Table 3.4 Leading Radio Frequency Identification (RFID) System Manufacturers, 2013
Table 3.5 Leading Pharmaceutical Taggants Manufacturers, 2013
Table 4.1 3M: Revenue ($m) and Revenue Shares (%) by Business Segment, 2012
Table 4.2 Alien Technologies: Types of RFID Readers Produced, 2013
Table 4.3 AlpVision: Products and Applications, 2013
Table 4.4 Angstrom Technologies: Products and Applications, 2013
Table 4.5 Avery Dennison: Revenue ($m) and Revenue Shares (%) by Business Segment, 2012
Table 4.6 Avery Dennison: RFID Products for Use in Pharmaceuticals, 2013
Table 4.7 Colorcon: Product Groups, Sub-groups, and Examples 2013
Table 4.8 Everest Holovision: Products and Applications, 2013
Table 4.9 InkSure Technologies: Products and Applications, 2013
Table 4.10 InkSure Technologies: Historical Revenue ($m, AGR %) 2009-2012
Table 4.11 Intermec: Product Lines and Descriptions, 2013
Table 4.12 Intermec: Historical Revenue ($m, AGR %) 2009-2012
Table 4.13 ThermoFisher Scientific: Historical Revenue ($bn) 2009-2012
Table 4.14 ThermoFisher Scientific: Revenue Shares (%) by Region, 2012
Table 4.15 UPM Raflatac: Product Groups and Descriptions, 2013
Table 4.16 Zebra Technologies: Product Groups and Descriptions, 2013
Table 4.17 Zebra Technologies: Historical Revenue ($m, AGR%) 2009-2012
Table 5.1 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) and Market Shares (%) by Sector, 2012
Table 5.2 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m, AGR%, CAGR%) by Sector, 2012-2017
Table 5.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m, AGR%, CAGR%) by Sector, 2017-2024
Table 5.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue ($m) by Sector, 2012, 2017, 2024
Table 5.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2012, 2017, 2024
Table 5.6 RFID: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.7 Security Printing: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.8 Pharmaceutical Taggants: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.9 Holograms/OVD: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.10 Other Technologies: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.1 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m, AGR%, CAGR%) by Region, 2012-2017
Table 6.2 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m, AGR%, CAGR%) by Region, 2017-2024
Table 6.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2012, 2017, 2024
Table 6.4 US Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.5 EU5 Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.6 Japanese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.7 Chinese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.8 Indian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%,
CAGR%), 2012-2024
Table 6.9 Brazilian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.10 Russian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Industry, 2014-2024
Table 7.2 Selected Instances of Counterfeiting Activities, 2012-2013
Table 7.3 Selected Instances of Counterfeiting Activities, 2009-2011
Table 7.4 STEP Analysis for the Pharmaceutical Anti-counterfeiting Technologies Industry, 2014-2024

List of Figures

Figure 2.1 Global Reported Incidents of Drug Counterfeiting, 2008-2012
Figure 2.2 Flow Chart of the Route Taken by Counterfeit Pharma Products Entering the Legal Supply Chain
Figure 3.1 Holograms Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 3.2 Basic Components of a RFID System
Figure 3.3 RFID Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 3.4 Taggants Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 3.5 Barcode Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 4.1 3M: Revenue Shares (%) by Business Segment, 2012
Figure 4.2 Authentix's Global Monitoring Service: A Three Step Program
Figure 4.3 Avery Dennison: Revenue Shares (%) by Business Segment, 2012
Figure 4.4 InkSure Technologies: Historical Revenue ($m) 2009-2012
Figure 4.5 Intermec: Historical Revenue ($m) 2009-2012
Figure 4.6 ThermoFisher Scientific: Historical Revenue ($bn) 2009-2012
Figure 4.7 ThermoFisher Scientific: Revenue Shares (%) by Region, 2012
Figure 4.8 Zebra Technologies: Historical Revenue ($m) 2009-2012
Figure 5.1 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Sector, 2012
Figure 5.2 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m), 2012- 2017
Figure 5.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m), 2017-2024
Figure 5.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue ($m) by Sector, 2012, 2017, 2024
Figure 5.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2012
Figure 5.6 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2017
Figure 5.7 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2024
Figure 5.8 RFID: Revenue Forecast ($m), 2012-2024
Figure 5.9 Security Printing: Revenue Forecast ($m), 2012-2024
Figure 5.10 Pharmaceutical Taggants: Revenue Forecast ($m), 2012-2024
Figure 5.11 Holograms/OVD: Revenue Forecast ($m), 2012-2024
Figure 5.12 Other Technologies Revenue Forecast ($m), 2012-2024
Figure 6.1 US and EU5 Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m), 2012-2024
Figure 6.2 China, India, Brazil and Russia Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m), 2012-2024
Figure 6.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2012
Figure 6.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2017
Figure 6.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2024
Figure 6.6 US Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.7 EU5 Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.8 Japanese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.9 Chinese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.10 Indian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.11 Brazilian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.12 Russian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 7.1 EU Supply Chain Authentication Strategy, 2013
Figure 7.2 US Supply Chain Authentication Strategy, 2013
Figure 9.1 Global Pharmaceutical Anti-counterfeiting Market: RFID, Security Printing, Holograms/OVD, and Taggants Revenue Forecast ($m), 2012-2024

Companies Listed

3M
Adhesives Research
Ahura Scientific
Alien Technologies
AlpVision
Altegrity Risk International
American Academy of Pediatrics (AAP)
American Express
AmerisourceBergen
Angstrom Technologies
Anti-Counterfeiting and Product Protection Programme (A-CAPPP)
Anti-Counterfeiting Group (ACG)
Apoteket
Applied DNA Sciences
ARmark Authentication Technologies LLC
AstraZeneca
Australian Therapeutic Goods Administration (TGA)
Authentix
Automation
Avery Dennison
Axway
Baxter
Canadian Anti-Counterfeiting Network (CACN)
Capsugel
Cellular Bioengineering Inc.
Center for Healthcare Supply Chain Research
Center for Medicine in the Public Interest (US)
CFC International
Chesapeake
Colorcon
Cortegra
Covectra
Digital China
Directorate General of Foreign Trade [India]
Domino
Drugs Standard Control Organisation
DuPont
European Alliance for Access to Safe Medicines (EAASM)
European Commission
European Directorate for the Quality of Medicines and Healthcare (EDQM),
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency
Europol
Everest Holovisions
GlaxoSmithKline (GSK)
Google
Healthcare Distribution Management Association (HDMA)
Heart UK
Hologram Industries
Holomex
HOMAI (hologram manufactures association of India)
Honeywell International
Image Solutions
Impinj Inc
Ingenia Technology
InkSure Technologies
Intermec/ Interface Mechanisms
International Anti-counterfeiting Association (IAA)
International Anti-Counterfeiting Coalition (IACC)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
International Ink Company
International Medical Products Anti-Counterfeiting Taskforce (IMPACT)
International Policy Network
Interpol
Japanese Pharmaceutical Manufacturers Association (JPMA)
Johnson & Johnson
Kodak
Loughborough University
LaserLock
Massachusetts Institute of Technology (MIT)
MasterCard
Medicines and Healthcare products Regulatory Agency (MHRA)
Medicrime Convention Council
Menasha Corporation
MicroTag Temed Ltd
Microtrace Solutions
Motorola
NanoGuardian
NanoInk Inc.
Nanotech Security Corp.
National Agency for Food and Drug Administration and Control (NAFDAC) [Nigeria]
National Association of Boards of Pharmacy (NABP)
National Health Surveillance Agency (ANVISA)
Neri Labels
Novartis
Novavision
OEP Technologie BV
One Equity Partners
OpSec Security
Organisation for Economic Co-operation and Development (OECD)
Pacific Holographics
Paralec Inc
Partner for Safe Medicines (PSM) India
Pera Innovations
Pfizer
Pharmaceutical Research and Manufacturers of America (PhRMA)
PharmaSecure
Quality Brands Protection Committee (QBPC) [China]
Reckitt Benckiser
Roche
Royal Pharmaceutical Society of Great Britain (RPSGB)
Sanofi
Savi Technology
ScanSource
Scientific Protein Laboratories (SPL)
SICPA
Siemens
Smartrac
South Dakota School of Mines and Technology
State Food and Drug Administration (SFDA) [China]
Sun Chemical
Symbol Technologies
Systech
Tagsys RFID
Teva Pharmaceuticals
Texas Instruments
The Caryle Group
The International Hologram Manufacturers Association
The Patients Association (UK)
The Pharmaceutical Security Institute (PSI)
ThermoFisher Scientific
TruTag Technologies
United Nations
University of South Dakota
UPM
UPM Kymmene
UPM Raflatac
UPM Rafsec z
US Center for Safe Internet Pharmacies (CSIP)
US Food and Drugs Agency (FDA)
US Pharmacopeial Convention (USP)
Visa
Vocollect Inc
Voxtel
Webscan
World Customs Organization
World Health Organization (WHO)
World Intellectual Property Organization (WIPO)
Zebra Technologies

To order this report: Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024
http://www.reportlinker.com/p0572966/Pharmaceutical-Anti-counterfeiting-Technologies-Market-Analysis-2014-2024.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
SYS-CON Events announced today that Elastifile will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Elastifile Cloud File System (ECFS) is software-defined data infrastructure designed for seamless and efficient management of dynamic workloads across heterogeneous environments. Elastifile provides the architecture needed to optimize your hybrid cloud environment, by facilitating efficient...
SYS-CON Events announced today that Cloudistics, an on-premises cloud computing company, has been named “Bronze Sponsor” of SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Launched in 2016, Cloudistics helps anyone bring the power of the cloud to the data center in an easy-to-use, on- premises cloud platform that automatically provides high performance resources for all types of applications: Docke...
SYS-CON Events announced today that Golden Gate University will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Since 1901, non-profit Golden Gate University (GGU) has been helping adults achieve their professional goals by providing high quality, practice-based undergraduate and graduate educational programs in law, taxation, business and related professions. Many of its courses are taug...
SYS-CON Events announced today that Golden Gate University will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Since 1901, non-profit Golden Gate University (GGU) has been helping adults achieve their professional goals by providing high quality, practice-based undergraduate and graduate educational programs in law, taxation, business and related professions. Many of its courses are taug...
SYS-CON Events announced today that Secure Channels, a cybersecurity firm, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Secure Channels, Inc. offers several products and solutions to its many clients, helping them protect critical data from being compromised and access to computer networks from the unauthorized. The company develops comprehensive data encryption security strategie...
Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service. However, the benefit of WebRTC for IoT is not only its convenience and interopera...
SYS-CON Events announced today that SkyScale will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. SkyScale is a world-class provider of cloud-based, ultra-fast multi-GPU hardware platforms for lease to customers desiring the fastest performance available as a service anywhere in the world. SkyScale builds, configures, and manages dedicated systems strategically located in maximum-security...
SYS-CON Events announced today that Datera will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Datera offers a radically new approach to data management, where innovative software makes data infrastructure invisible, elastic and able to perform at the highest level. It eliminates hardware lock-in and gives IT organizations the choice to source x86 server nodes, with business model option...
SYS-CON Events announced today that DXWorldExpo has been named “Global Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Digital Transformation is the key issue driving the global enterprise IT business. Digital Transformation is most prominent among Global 2000 enterprises and government institutions.
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
SYS-CON Events announced today that Massive Networks will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Massive Networks mission is simple. To help your business operate seamlessly with fast, reliable, and secure internet and network solutions. Improve your customer's experience with outstanding connections to your cloud.
When shopping for a new data processing platform for IoT solutions, many development teams want to be able to test-drive options before making a choice. Yet when evaluating an IoT solution, it’s simply not feasible to do so at scale with physical devices. Building a sensor simulator is the next best choice; however, generating a realistic simulation at very high TPS with ease of configurability is a formidable challenge. When dealing with multiple application or transport protocols, you would be...
SYS-CON Events announced today that Akvelon will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Akvelon is a business and technology consulting firm that specializes in applying cutting-edge technology to problems in fields as diverse as mobile technology, sports technology, finance, and healthcare.
SYS-CON Events announced today that Secure Channels, a cybersecurity firm, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Secure Channels, Inc. offers several products and solutions to its many clients, helping them protect critical data from being compromised and access to computer networks from the unauthorized. The company develops comprehensive data encryption security strategie...
SYS-CON Events announced today that WineSOFT will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Based in Seoul and Irvine, WineSOFT is an innovative software house focusing on internet infrastructure solutions. The venture started as a bootstrap start-up in 2010 by focusing on making the internet faster and more powerful. WineSOFT’s knowledge is based on the expertise of TCP/IP, VPN, SS...
WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web communications world. The 6th WebRTC Summit continues our tradition of delivering the latest and greatest presentations within the world of WebRTC. Topics include voice calling, video chat, P2P file sharing, and use cases that have already leveraged the power and convenience of WebRTC.
SYS-CON Events announced today that App2Cloud will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct. 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. App2Cloud is an online Platform, specializing in migrating legacy applications to any Cloud Providers (AWS, Azure, Google Cloud).
When shopping for a new data processing platform for IoT solutions, many development teams want to be able to test-drive options before making a choice. Yet when evaluating an IoT solution, it’s simply not feasible to do so at scale with physical devices. Building a sensor simulator is the next best choice; however, generating a realistic simulation at very high TPS with ease of configurability is a formidable challenge. When dealing with multiple application or transport protocols, you would be...
An increasing number of companies are creating products that combine data with analytical capabilities. Running interactive queries on Big Data requires complex architectures to store and query data effectively, typically involving data streams, an choosing efficient file format/database and multiple independent systems that are tied together through custom-engineered pipelines. In his session at @BigDataExpo at @ThingsExpo, Tomer Levi, a senior software engineer at Intel’s Advanced Analytics ...
Internet-of-Things discussions can end up either going down the consumer gadget rabbit hole or focused on the sort of data logging that industrial manufacturers have been doing forever. However, in fact, companies today are already using IoT data both to optimize their operational technology and to improve the experience of customer interactions in novel ways. In his session at @ThingsExpo, Gordon Haff, Red Hat Technology Evangelist, shared examples from a wide range of industries – including en...